New Research Reveals How Pancreatic Cancer Suppresses Important Gene
New research published in the journal Gastro Hep Advances has shed light on how pancreatic cancer manages to grow and spread, revealing a key gene that is turned off in the process.
Pancreatic cancer is known to be one of the most aggressive human diseases, with a low survival rate and limited treatment options. Researchers at the John van Geest Cancer Research Center at Nottingham Trent University have discovered that pancreatic cancer utilizes a process called DNA methylation to deactivate the HNF4A gene, which is crucial for the proper function of many organs.
Maria Hatziapostolou, a researcher involved in the study, emphasized the importance of understanding the disease better in order to find new ways to combat it. The deactivation of the HNF4A gene allows cancer cells to spread rapidly, contributing to the aggressiveness of the disease.
Chris Macdonald, director of Pancreatic Cancer UK, highlighted the urgent need for more effective treatment options for pancreatic cancer, especially since the majority of cases are detected only after the disease has already spread. The new research findings offer hope for the development of treatments that target the gene deactivation process and potentially improve patient outcomes.
The study’s findings have sparked optimism among researchers and advocates in the field, who see this discovery as a potential breakthrough in the fight against pancreatic cancer. With further research and development, these new insights could pave the way for more effective treatments that target the root cause of the disease’s rapid spread.
